CBD Helps Connecticut Chiropractor With Lyme Disease To Quit OTC Medications

November 20, 2019 09:00:01

If you haven’t been living under a rock for the past few years, you have undoubtedly heard about cannabidiol (CBD). The cannabis extract has been impressing consumers with its medicinal properties, and it is set to be one of, if not the most, versatile medicines of the century. The compound has been found effective against a host of conditions ranging from chronic pain to seizures in rare childhood epilepsies.

At least 40% of the people who use CBD do so for pain relief. Gene Gresh, a compounding pharmacist, says, “Anecdotally, we see amazing pain relief qualities when it’s used topically. When used orally, we see things like reduced anxiety and depression and improved sleep.” One of the people who’ve benefited greatly from…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.